Study the Latest Developments in the Influenza Drug Pipeline With New Report
Posted on: Wednesday, 12 September 2007, 09:02 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c68213) has announced the addition of Infections - Influenza Drug Pipeline Report to their offering.
"Infections - Influenza Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of influenza drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Influenza Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Legend
--Top 20 companies in late stage Influenza Projects
--Top 20 companies in early stage Influenza Projects
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c68213
Source: Life Science Analytics
Source: Business Wire
Related Articles
- Lockheed Martin SBIRS Team Advancing to Follow-on Production Phase
- Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
- PSTS China to Commence Production Expansion Project
- GO Networks Wins Product Acceptance By U.S. Govt. Rural Development Telecommunications Program
- Morse LLC Announces Intent to Develop Proton Therapy Center in South Florida Using Technology From Varian Medical Systems
- LAWA Appoints David Shuter As the New Deputy Executive Director of Project and Facilities Development Services
- AGTC and JDRF Announce Partnership to Develop Gene Therapy for Diabetic Eye Disease
- FMC Technologies Awarded Subsea Systems Contract for Statoil Vigdis Extension Phase 2 Project
- Green Hills Software and I-Logix Redefine ``Integrated Development Environment'' With First Single Source Solution Addressing All Phases of Embedded Systems Development
- Project Aims to Develop Hydrogen Power
 |
 |
User Comments (0)
RSS Feeds